Physician

Anshu Hemrajani

According to 2025 Medicare claims, Anshu Hemrajani (NPI: 1548653231) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60026-1339.

Hemrajani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 161 traditional Medicare patients, billed 437 HCPCS/CPT codes, and received $35,376 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 586 prescription claims across 121 beneficiaries totaling $418,624 in drug costs, led by Kisqali (Ribociclib Succinate). 2020 DME data shows 24 claims. Open Payments data shows 1 records totaling $10,000. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,051 to $418,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$18K$35K2023 Medicare payment: $9,579 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $35,376 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20235490$9,579
2024161437$35,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$209K$419K2017 Drug cost: $2,051 (USD; Tot_Drug_Cst)2018 Drug cost: $8,337 (USD; Tot_Drug_Cst)2019 Drug cost: $10,545 (USD; Tot_Drug_Cst)2020 Drug cost: $4,964 (USD; Tot_Drug_Cst)2021 Drug cost: $861 (USD; Tot_Drug_Cst)2023 Drug cost: $1,416 (USD; Tot_Drug_Cst)2024 Drug cost: $418,624 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171436$2,051
201843147$8,337
201936164$10,545
20202779$4,964
2021N/R23$861
2022N/RN/RN/R
20233685$1,416
2024121586$418,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.7K$3.3K2019 Medicare payment: $685 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,313 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R12$685
2020N/R24$3,313
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4949$149
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2031$114
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2121$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more47119$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more73126$53

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KisqaliRibociclib Succinate22616$326,314
AnastrozoleAnastrozole27917,748$4,657
ExemestaneExemestane20900$1,781
LetrozoleLetrozole784,590$1,215
NystatinNystatin14140$355

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.1$10,000PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anshu Hemrajani?

Tedicare shows public-source Medicare data for Anshu Hemrajani (NPI 1548653231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anshu Hemrajani have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anshu Hemrajani?

Anshu Hemrajani is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Anshu Hemrajani have Open Payments data?

Anshu Hemrajani has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.